Abstract:Objective·To investigate the composition of immune cells in tumor microenvironment of colorectal cancer (CRC), and examine the proportion, phenotype and effector function of natural killer (NK) cells in CRC.Methods·Fresh tumor tissues, paired normal tissues adjacent to tumor, and peripheral blood samples in the same cohort were collected from CRC patients. Tissues were digested and prepared into single cell suspension. The major immune cell lineages were detected by flow cytometry. t-Distributed stochastic neighbor embedding (t-SNE) and statistical analysis were used to analyze the composition of immune cells in tumor microenvironment of CRC. To analyze the phenotype of NK cells, the expression levels of activation markers, including CD16, CD27, CD69, human leukocyte antigen-DR (HLA-DR), and T cell immunoglobulin domain and mucin domain-3 (TIM-3), were detected by flow cytometry. NK cell subsets: CD38lowNK cells and CD38highNK cells were also examined by flow cytometry. To assess the effector function of NK cells, they were stimulated with cell stimulation cocktail and the expression levels of interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured by flow cytometry.Results·Twenty-five pairs of fresh tumor tissues and normal tissues adjacent to tumor, and 15 peripheral blood samples in the same cohort were collected from CRC patients. The tumor microenvironment of CRC included diverse immune cell types, including T cells, B cells, NK cells and myeloid cells. The proportions of T cells (P=0.000) and myeloid cells (P=0.026) in tumor tissues were significantly higher than those in normal tissues. By contrast, the proportion of NK cells (P=0.007) in tumor was significantly reduced. The proportion of B cells was comparable between tumor and normal tissues. Compared to normal tissues, NK cells in tumor tissues expressed significantly lower CD27 (P=0.000) and CD69 (P=0.001), while the expression levels of CD16 (P=0.008), HLA-DR (P=0.000) and TIM-3 (P=0.024) were significantly elevated. The results indicated that NK cells in CRC tumor exhibited a phenotype of late activation and exhaustion. According to the expression level of CD38, NK cells could be divided into two subsets, CD38highNK cells and CD38lowNK cells. The proportion of CD38highNK cells (P=0.003) in tumor tissues was significantly lower than that in normal tissues, while the proportion of CD38lowNK cells was unaffected. Compared to CD38lowNK cells, CD38highNK cells expressed higher CD27, meanwhile significantly less CD16, NKp46, CD57, CD94, HLA-DR and CD158a (P=0.000). These results suggested that CD38highNK cells were at early differentiation state. The secretion of cytokines IFN-γ (P=0.032), TNF-α (P=0.042), and GM-CSF (P=0.019) by tumor-infiltrated NK cells was significantly decreased compared to that in normal tissues. The results showed that the function of tumor-infiltrated NK cells was impaired.Conclusion·Together, these data suggest that NK cell compartment is disrupted in tumor tissues of CRC, leading to the impaired anti-tumor immunity mediated by NK cells.

Decrease in natural killer cell associated gene expression as a major characteristic of the immune status in the bloodstream of colorectal cancer patients.

Identification of Necroptosis-Related Long Noncoding RNAs for Immunotherapy Selection and Prognosis Prediction in Patients with Colorectal Cancer

Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-like Receptor Pathway Deregulation in Colorectal Cancer.

Peripheral blood mRNA signature for colorectal cancer screening.

Data from Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer

Natural killer cell-related prognosis signature predicts immune response in colon cancer patients

Use of Peripheral Blood Mrna Signatures to Distinguish Colorectal Cancer Patients from Colonoscopy-Negative Patients

Possible Association Of Decreased Nkg2d Expression Levels And Suppression Of The Activity Of Natural Killer Cells In Patients With Colorectal Cancer

Changes in subset distribution and impaired function of circulating natural killer cells in patients with colorectal cancer

Identification Of Potential Biomarkers For Risk Analysis Of Colorectal Cancer Using A Combined Bioinformatics Analysis

Colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes

The Effect of Colonoscopy on Whole Blood Gene Expression Profile: an Experimental Investigation for Colorectal Cancer Biomarker Discovery

Gene expression profile of human colorectal cancer identified NKTR as a biomarker for liver metastasis

Immune-related Gene Expression Signatures in Colorectal Cancer.

Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma

The synchronous upregulation of a specific protein cluster in the blood predicts both colorectal cancer risk and patient immune status

Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing

Phenotype and Function of NK Cell in Colorectal Cancer

Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer

The Prognostic Significance of Peripheral T-lymphocyte Subsets and Natural Killer Cells in Patients with Colorectal Cancer.

An Analysis of the Gene Expression Associated with Lymph Node Metastasis in Colorectal Cancer